切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2024, Vol. 13 ›› Issue (02) : 68 -73. doi: 10.3877/cma.j.issn.2095-3216.2024.02.002

论著

过敏性紫癜性肾炎患儿肾功能不全的影响因素分析
刘宇立1,(), 姚瑶1, 徐锦雯1   
  1. 1. 214000 无锡市儿童医院肾脏风湿免疫科
  • 收稿日期:2023-01-31 出版日期:2024-04-28
  • 通信作者: 刘宇立
  • 基金资助:
    无锡市卫健卫科研项目(MS201759)

Analysis of influencing factors of renal insufficiency in children with Henoch-Schönlein purpura nephritis

Yuli Liu1,(), Yao Yao1, Jinwen Xu1   

  1. 1. Department of Nephrology & Rheumatology, Wuxi Children′s Hospital, Wuxi 214000, Jiangsu Province, China
  • Received:2023-01-31 Published:2024-04-28
  • Corresponding author: Yuli Liu
引用本文:

刘宇立, 姚瑶, 徐锦雯. 过敏性紫癜性肾炎患儿肾功能不全的影响因素分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 68-73.

Yuli Liu, Yao Yao, Jinwen Xu. Analysis of influencing factors of renal insufficiency in children with Henoch-Schönlein purpura nephritis[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(02): 68-73.

目的

分析过敏性紫癜性肾炎患儿肾功能不全的影响因素。

方法

回顾性分析在我院治疗的165例过敏性紫癜性肾炎患儿的临床资料,收集IgG亚类的血清水平。Cox回归模型分析患儿肾功能不全的影响因素。

结果

肾功能不全发生率为35.15%;发生肾功能不全患儿的IgG1、IgG2、IgG3、IgG4水平均低于未发生者(P<0.05)。IgG1(RR=0.435,95%CI:0.249~0.671,P=0.013)、IgG2(RR=0.452,95%CI:0.302~0.668,P=0.010)、IgG3(RR=0.396,95%CI:0.245~0.676,P=0.012)、IgG4(RR=0.471,95%CI:0.220~0.668,P=0.018)是肾功能不全的保护因素。皮疹反复(RR=4.189,95%CI:2.637~5.952,P=0.019)、血小板计数升高(RR=4.157,95%CI:2.881~4.762,P<0.001)、血压升高(RR=5.220,95%CI:2.314~6.888,P=0.001)、血糖升高(RR=5.125,95%CI:3.582~6.720,P<0.001)、贫血(RR=5.231,95%CI:4.037~7.869,P=0.007)、新月体形成(RR=5.172,95%CI:3.562~7.074,P=0.004)、肾小管萎缩(RR=5.519,95%CI:3.289~6.968,P=0.021)、肾间质纤维化(RR=6.460,95%CI:4.560~7.887,P=0.003)、治疗不依从(RR=4.994,95%CI:3.462~6.840,P=0.001)是其危险因素。

结论

IgG亚类水平和皮疹反复、血小板升高、血压升高、血糖升高、贫血、新月体形成、肾小管萎缩、肾间质纤维化、治疗不依从为过敏性紫癜性肾炎患儿肾功能不全影响因素。

Objective

To investigate the influencing factors of renal insufficiency in children with Henoch-Schönlein purpura nephritis.

Methods

The clinical data of 165 children with Henoch-Schönlein purpura nephritis treated in our hospital were retrospectively analyzed. Levels of serum IgG subclasses were collected. Cox regression model was used to analyze the influencing factors of renal insufficiency in the children with Henoch-Schönlein purpura nephritis.

Results

The incidence of renal insufficiency was 35.15%. The levels of IgG1, IgG2, IgG3, and IgG4 in the patients with renal insufficiency were lower than those in the patients without renal insufficiency (P<0.05). IgG1 (RR=0.435, 95%CI: 0.249-0.671, P=0.013), IgG2 (RR=0.452, 95%CI: 0.302-0.668, P=0.010), IgG3 (RR=0.396, 95%CI: 0.245-0.676, P=0.012), and IgG4 (RR=0.471, 95%CI: 0.220-0.668, P=0.018) were the protective factors against renal insufficiency (P<0.05). Repeated rash (RR=4.189, 95%CI: 2.637-5.952, P=0.019), elevated platelet count (RR=4.157, 95%CI: 2.881-4.762, P<0.001), elevated blood pressure (RR=5.220, 95%CI: 2.314-6.888, P=0.001), elevated blood glucose (RR=5.125, 95%CI: 3.582-6.720, P<0.001), anemia (RR=5.231, 95%CI: 4.037-7.869, P=0.007), crescent formation (RR=5.172, 95%CI: 3.562-7.074, P=0.004), renal tubular atrophy (RR=5.519, 95%CI: 3.289-6.968, P=0.021), renal interstitial fibrosis (RR=6.460, 95%CI: 4.560-7.887, P=0.003), and non-compliance with treatment (RR=4.994, 95%CI: 3.462-6.840, P=0.001) were risk factors for the renal insufficiency (P<0.05).

Conclusion

IgG subclasses levels, repeated rash, elevated platelets, elevated blood pressure, elevated blood glucose, anemia, crescent formation, tubular atrophy, renal interstitial fibrosis, and non-compliance with treatment were the influencing factors of renal insufficiency in the children patients with Henoch-Schönlein purpura nephritis.

图1 研究对象筛选流程
表1 发生肾功能不全和未发生过敏性紫癜性肾炎患儿肾功能指标(±s)
表2 肾功能不全发生与未发生过敏性紫癜性肾炎患儿资料比较
可能影响因素 肾功能不全发生(n=58) 肾功能不全未发生(n=107) χ2/t P OR值(95%CI)
性别          
34(58.62) 65(60.75) 0.071 0.790 0.935(0.876~1.138)
24(41.38) 42(39.25)      
年龄 6.90±1.02 7.28±1.40 1.821 0.070 0.915(0.783~1.320)
发病季节          
春夏 25(43.10) 49(45.79) 0.110 0.740 0.973(0.912~1.054)
秋冬 33(56.90) 58(54.21)      
消化道症状          
35(60.34) 56(52.34) 0.975 0.323 1.102(0.968~1.267)
23(39.66) 51(47.66)      
关节疼痛          
26(44.83) 60(56.07) 1.907 0.167 0.885(0.814~1.160)
32(55.17) 47(43.93)      
皮疹反复a          
43(74.14) 48(44.86) 13.035 <0.001 4.205(3.760~5.241)
15(25.86) 59(55.14)      
血小板          
正常 18(31.03) 54(50.47) 5.775 0.016 4.056(3.438~4.873)
升高 40(68.97) 53(49.53)      
IgG1(g/L) 3.07±0.52 3.86±0.67 7.793 <0.001 0.418(0.253~0.702)
IgG2(g/L) 0.99±0.14 1.12±0.24 3.787 <0.001 0.471(0.305~0.696)
IgG3(g/L) 0.42±0.07 0.56±0.11 8.771 <0.001 0.402(0.316~0.569)
IgG4(g/L) 0.36±0.07 0.43±0.08 5.601 <0.001 0.477(0.432~0.605)
血压升高b          
38(65.52) 27(25.23) 25.565 <0.001 5.206(4.735~5.897)
20(34.48) 80(74.77)      
收缩压(mmHg) 93.58±9.73 88.75±8.06 3.412 0.001 4.896(3.917~5.042)
舒张压(mmHg) 73.05±8.46 62.50±7.22 8.429 <0.001 5.923(4.741~6.228)
血糖升高          
32(55.17) 19(17.76) 20.138 <0.001 5.116(4.721~5.483)
26(44.83) 88(82.24)      
贫血          
24(41.38) 18(16.82) 11.953 0.001 5.289(4.473~5.994)
34(58.62) 89(83.18)      
血小板计数(×109/L) 136.74±20.52 141.85±22.69 1.427 0.155 0.875(0.763~1.054)
肉眼血尿(管型)          
2(3.45) 0(0.00) 1.410 0.235 1.015(0.883~1.245)
56(96.55) 107(100.00)      
24 h尿蛋白定量(mg) 104.50±31.45 102.65±29.04 0.379 0.705 0.894(0.541~1.162)
新月体形成          
50(86.21) 36(33.64) 41.640 <0.001 5.321(5.011~5.796)
8(13.79) 71(66.36)      
肾小管萎缩          
52(89.68) 38(35.51) 44.468 <0.001 5.645(4.869~5.976)
6(10.34) 79(64.49)      
肾间质纤维化          
48(82.76) 26(24.30) 51.968 <0.001 6.543(5.678~6.962)
10(17.24) 81(75.70)      
治疗不依从          
5(8.62) 0(0.00) 13.695 <0.001 4.966(4.405~5.112)
53(91.38) 107(100.00)      
表3 变量赋值
表4 肾功能不全的影响因素Cox回归模型分析
[22]
Cheng HD, Tirosh I, de Haan N, et al. IgG Fc glycosylation as an axis of humoral immunity in childhood [J]. J Allergy Clin Immunol, 2020, 145(2): 710-713.
[23]
蔡浩,王强,赵风云. 过敏性紫癜患儿血浆C3,C4,IgA水平变化及其与肾脏损伤的关系[J]. 山东医药2021, 61(14): 82-84.
[24]
李华荣,陈朝英,涂娟,等. 儿童紫癜性肾炎预后不良相关因素分析[J]. 中华肾脏病杂志2020, 36(7): 535-542.
[25]
吴军,张芳玲. 影响过敏性紫癜患者肾损伤的独立危险因素分析[J]. 安徽医学2020, 41(8): 936-939.
[1]
Wang Z, Chen L, Zhang F, et al. First-in-patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura [J]. J Thromb Haemost, 2020, 18(11): 3053-3060.
[2]
Leung AKC, Barankin B, Leong KF. Henoch-Schönlein purpura in children: an updated review [J]. Curr Pediatr Rev, 2020, 16(4): 265-276.
[3]
高春林,夏正坤. 从过敏性紫癜到IgA血管炎——发病机制新认识[J]. 中国实用儿科杂志2022, 37(1): 12-16.
[4]
Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease [J]. Am J Med Sci, 2021, 361(2): 176-194.
[5]
雷晓燕,王三萍,熊海金,等. 儿童紫癜性肾炎IgG亚类变化观察[J]. 临床儿科杂志2005, 23(11): 792-793, 796.
[6]
中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志2017, 55(9): 647-651.
[7]
林源. 儿童肾脏病诊断与治疗[M]. 长春:吉林科学技术出版社,2012: 144-148.
[8]
Kim WK, Kim CJ, Yang EM. Risk factors for renal involvement in Henoch-Schönlein purpura [J]. J Pediatr (Rio J), 2021, 97(6): 646-650.
[9]
褚会敏,王金娟,潘月丽. 基于机器学习算法的儿童过敏性紫癜肾损害风险预测[J]. 中国预防医学杂志2022, 23(1): 62-67.
[10]
朱小波,范海燕,刘金祥. 山莨菪碱结合孟鲁司特治疗过敏性紫癜患儿的临床研究及复发的危险因素分析[J]. 实用医学杂志2021, 37(3): 385-389.
[11]
杨剑敏,姜林林,高原,等. 外周血免疫细胞,免疫球蛋白,补体及Gd-IgA1在儿童过敏性紫癜中的表达及意义[J]. 检验医学与临床2021, 18(23): 3391-3394, 3398.
[12]
Luo X, Tan J, Wan D, et al. Predictability of the Oxford classification of IgA nephropathy in Henoch-Schönlein purpura nephritis [J]. Int Urol Nephrol, 2022, 54(1): 99-109.
[13]
周彬,党小宁,傅忠国,等. 紫癜性肾炎患儿血清PTX3,IgA/C3水平变化及与肾功能损伤的相关性[J]. 武警医学2021, 32(3): 193-196.
[14]
Hastings MC, Rizk DV, Kiryluk K, et al. IgA vasculitis with nephritis: update of pathogenesis with clinical implications [J]. Pediatr Nephrol, 2022, 37(4): 719-733.
[15]
赵晨,赵萍,白燕,等. 过敏性紫癜儿童血清特异性免疫球蛋白E和免疫球蛋白G检测分析[J]. 中国医刊2021, 56(2): 212-215.
[16]
Caza TN, Hassen SI, Dvanajscak Z, et al. NELL1 is a target antigen in malignancy-associated membranous nephropathy [J]. Kidney Int, 2021, 99(4): 967-976.
[17]
张健,吴国荣,孙果,等. 无锡地区皮肤病患儿血清食物特异性IgG的检测结果分析[J]. 中国免疫学杂志2020, 36(11): 1365-1369.
[18]
Nasr SH, Kudose SS, Said SM, et al. Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants [J]. Kidney Int, 2021, 99(2): 410-420.
[19]
Kudose S, Santoriello D, Debiec H, et al. The clinicopathologic spectrum of segmental membranous glomerulopathy [J]. Kidney Int, 2021, 99(1): 247-255.
[20]
Kuhnel L, Hawley CM, Johnson DW, et al. Allograft failure in kidney transplant recipients who developed kidney failure secondary to ANCA-associated vasculitis [J]. Clin Transplant, 2021, 35(4): e14235.
[21]
Rossi D, Sciascia S, Fenoglio R, et al. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy [J]. Minerva Med, 2021, 112(2): 162-174.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[4] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[5] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[6] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[7] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[8] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[9] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[10] 陈意志. 核磁共振钆造影剂导致的肾源性系统性纤维化[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 358-358.
[11] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[12] 房桂彬, 肖进, 傅光涛, 郑秋坚. 老年髋部骨折患者术后1年行走能力的影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 273-280.
[13] 单良, 刘怡, 于涛, 徐丽. 老年股骨颈骨折术后患者心理弹性现状及影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 294-300.
[14] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要